Lloyd George W.

EVP, Investments & CLORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Nov 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.2M
Net Open-Market Flow
-$5.2M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 19, 2025Sell(S)5K$39.01$179K0
Nov 19, 2025Sell(S)230$39.03$9K0
Nov 19, 2025Sell(S)48K$38.28$1.8M11K
Nov 19, 2025Sell(S)5K$39.01$181K6K
Nov 19, 2025Sell(S)47K$38.28$1.8M5K
Nov 19, 2025Sell(S)26K$38.28$977K2K
Nov 19, 2025Sell(S)2K$39.01$96K0
Nov 19, 2025Sell(S)3K$38.29$106K230

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814899-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RPRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001814899-25-000006"
Ask your agent
Use Arkolith to summarize insider buying and selling at Royalty Pharma plc
over the last 90 days and cite the filings.